The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five. The ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has partnered with Stayhealthy, Inc. to distribute Stayhealthy’s Multi-Risk Test across North America, marking a ...

Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health and wellness space across global markets along with its expanding product portfolio ...

Genetic Technologies (NASDAQ:GENE) stock tumbled 26% in afternoon trading Thursday after the genomics-based test developer announced a $2M registered direct offering. Shares of Genetic Technologies ...

Nearly 80% of people in Australia and the U.S. that used Genetic Technologies Ltd.’s Genetype multi-risk assessment test showed an elevated risk for at least one disease covered by the test.

Genetic Technologies ( ($AU:GTG) ) has issued an update. Genetic Technologies Limited announced the resignation of Mr. Mark Ziirsen as the Joint ...

Genetic Technologies (NASDAQ:GENE) said Friday its June-quarter receipts were A$2.1 million. At the end of June 2023, the company had A$7.9 million in cash and cash equivalents. Cash receipts from ...